Literature DB >> 9237495

Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteries.

L Edvinsson1, L Cantera, I Jansen-Olesen, R Uddman.   

Abstract

Reverse transcriptase polymerase chain reaction (RT-PCR) using primers for the recently cloned human CGRP1 receptor detected mRNA expression of CGRP1 receptors in trigeminal ganglia and cerebral vessels, obtained at autopsy or during neurosurgical tumor resections. An RT-PCR product of the expected size (339 bp) was seen in cerebral arteries, both in the presence and in the absence of endothelium and in trigeminal ganglia. Sequence analysis of the RT-PCR product of the published sequence showed 100% homology with the human CGRP1 receptor. The presence of the CGRP1 receptor mRNA in human trigeminal ganglia and cerebral blood vessels, indicates the occurrence of both prejunctional (trigeminal) and postjunctional location (blood vessels) of the CGRP1 receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237495     DOI: 10.1016/s0304-3940(97)00456-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals.

Authors:  A Sams-Nielsen; C Orskov; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 2.  CGRP receptor antagonism and migraine.

Authors:  Lars Edvinsson; Tony W Ho
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

3.  Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.

Authors:  Ilya Buldyrev; Nathan M Tanner; Hui-ya Hsieh; Emily G Dodd; Loi T Nguyen; Agnieszka Balkowiec
Journal:  J Neurochem       Date:  2006-10-25       Impact factor: 5.372

4.  Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.

Authors:  Sajedeh Eftekhari; Lars Edvinsson
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

Review 5.  Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

Authors:  L Edvinsson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.

Authors:  Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Neurobiol       Date:  2008-05-06       Impact factor: 5.590

7.  CGRP receptor antagonists: A new frontier of anti-migraine medications.

Authors:  Blanca Marquez de Prado; Andrew F Russo
Journal:  Drug Discov Today Ther Strateg       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.